Diabetic ketoacidosis treatment during COVID-19 pandemic in a country with scarce health resources.

Gutiérrez-Ortiz, Claudia C; Concepción-Zavaleta, Marcio J; García-Villasante, Eilhart J

Gutiérrez-Ortiz, Claudia C; Concepción-Zavaleta, Marcio J; García-Villasante, Eilhart J.

Gutiérrez-Ortiz CC; Universidad Nacional Mayor de San Marcos, Division of Endocrinology, Hospital Nacional Daniel Alcides Carrion, Lima, Peru. Electronic address: cecilia_gut09@hotmail.com.
Concepción-Zavaleta MJ; Universidad Nacional Mayor de San Marcos, Division of Endocrinology, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.
García-Villasante EJ; Universidad Nacional Mayor de San Marcos, Division of Endocrinology, Hospital Nacional Daniel Alcides Carrion, Lima, Peru.

Diabetes Metab Syndr ; 14(6): 1847-1848, 2020.

Article in English | MEDLINE | ID: covidwho-1059096

Subject(s)

COVID-19/epidemiology; Diabetic Ketoacidosis/drug therapy; Diabetic Ketoacidosis/epidemiology; Health Resources/trends; Insulin/administration & dosage; COVID-19/economics; Diabetic Ketoacidosis/economics; Health Resources/economics; Humans; Insulin/economics; Pandemics

Keywords

COVID-19; Diabetic ketoacidosis; Health resources

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetic Ketoacidosis / COVID-19 / Health Resources / Insulin Type of study: Observational study Limits: Humans Language: English Journal: Diabetes Metab Syndr Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google